Patents by Inventor Erin Dickerson

Erin Dickerson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for targeting interleukin-12 to malignant endothelium
    Publication number: 20050063948
    Abstract: Fusion proteins containing a mammalian interleukin-12 operably linked to an RGD-containing peptide as well as nucleic acid sequences, vectors and host cells for expression of these fusion proteins are provided. Also provided are methods of using these fusion proteins to inhibit tumor growth and to decrease the toxicity associated with interleukin-12 administration.
    Type: Application
    Filed: August 13, 2004
    Publication date: March 24, 2005
    Inventors: Erin Dickerson, Stuart Helfand, Nasim Akhtar
  • Malignant endothelial cell line and uses thereof in models for angiogenesis
    Publication number: 20050054089
    Abstract: An immortalized hemangiosarcoma cell line of malignant canine endothelial cells which possesses surface expression characteristics and growth factor and cytokine expression profiles typical of nonmalignant activated endothelial cells is provided. In vitro and in vivo models for angiogenesis produced from this cell line as well as methods for identifying antiangiogenic agents using these models are also provided.
    Type: Application
    Filed: September 5, 2003
    Publication date: March 10, 2005
    Inventors: Stuart Helfand, Nasim Akhtar, Erin Dickerson, Marcia Padilla